These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24011935)

  • 1. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
    Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
    Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
    Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
    Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
    Solon JG; O'Neill M; Chang KH; Deady S; Cahill R; Moran B; Shields C; Mulsow J
    Eur J Surg Oncol; 2017 Oct; 43(10):1924-1931. PubMed ID: 28583791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal metastases from extra-abdominal cancer - A population-based study.
    Flanagan M; Solon J; Chang KH; Deady S; Moran B; Cahill R; Shields C; Mulsow J
    Eur J Surg Oncol; 2018 Nov; 44(11):1811-1817. PubMed ID: 30139510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
    Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
    Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012.
    Schroten-Loef C; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP
    Eur J Cancer; 2018 Sep; 101():77-86. PubMed ID: 30031970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
    Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands.
    Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A
    J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.
    Thomassen I; van Gestel YR; van Ramshorst B; Luyer MD; Bosscha K; Nienhuijs SW; Lemmens VE; de Hingh IH
    Int J Cancer; 2014 Feb; 134(3):622-8. PubMed ID: 23832847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study.
    Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT
    Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
    Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
    Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma of unknown primary origin: a population-based study in the Netherlands.
    de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
    Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.
    Klaver YL; Leenders BJ; Creemers GJ; Rutten HJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Am J Clin Oncol; 2013 Apr; 36(2):157-61. PubMed ID: 22314003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases.
    Elias D; Goéré D; Dumont F; Honoré C; Dartigues P; Stoclin A; Malka D; Boige V; Ducreux M
    Eur J Cancer; 2014 Jan; 50(2):332-40. PubMed ID: 24157254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.